Skip to main content
. 2021 May 15;37(2):115–120. doi: 10.5146/tjpath.2020.01519

Figure 2.

Figure 2

A) Pancreatic ductal adenocarcinoma (PDAC), moderately differentiated (H&E; x100). B) Three moderately differentiated PDACs were diffusely and strongly positive for calretinin (IHC; x100). C) One additional case was focally positive for calretinin (IHC; x100).